Product Information

CARBAMAZEPINE 100 MG/5 ML SUSP is a generic product labeled by Chartwell RX LLC, priced at $0.0960 per ML under NDC 62135080253. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE 100 MG/5 ML SUSP

Carbamazepine
$0.0960per ML

Strength

100 mg/5mL

Manufacturer

Chartwell RX LLC

NDC

62135080253

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA075714

FDA Approved

6/5/2002

TE Code

AB

On Market Since

6/5/2002

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0960 per ML
All-time high$0.1174 (May 15, 2024)
All-time low$0.0955 (Jul 22, 2026)
52-week high$0.1134
52-week low$0.0955
Median price$0.1103
Average price$0.1088
Largest weekly change-8.1% (Jul 17, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

+0.5%

1M

+0.5%

3M

-4.6%

6M

-8.2%

1Y

-11.6%

3Y

N/A

5Y

N/A

All

-12.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE 100 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 100 MG/5 ML SUSP, manufactured by Chartwell RX LLC, is $0.0960 per ML (NDC 62135080253), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE 100 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has declined 12.5%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 100 MG/5 ML SUSP?

Since Mar 13, 2024, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has ranged from a low of $0.0955 (Jul 22, 2026) to a high of $0.1174 (May 15, 2024), with a median of $0.1103 per ML.

Are there cheaper alternatives to CARBAMAZEPINE 100 MG/5 ML SUSP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE 100 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBAMAZEPINE 100 MG/5 ML SUSP?

CARBAMAZEPINE 100 MG/5 ML SUSP (NDC 62135080253) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.